dr. atkins on sequencing of immunotherapy combination regimens for rcc
Published 7 years ago • 121 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
0:53
dr. chowdhury on sequencing of immunotherapy regimens for rcc
-
1:58
dr. atkins on excitement with atezolizumab and bevacizumab in rcc
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
7:20
emerging immunotherapy combinations in kidney cancer
-
6:38
rcc: following patients on immunotherapy vs tki therapy
-
2:16
dr. amin on toxicities with immunotherapy/tki combinations in rcc
-
1:16
dr. mcdermott on toxicities of immunotherapy combinations in rcc
-
6:56
sequencing approaches in metastatic renal cell carcinoma
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
1:55
dr. kim on combining immunotherapy and tkis in metastatic rcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
2:16
the agents at the forefront of kidney cancer treatment
-
2:07
dr. mcdermott on tki/immunotherapy combinations in rcc
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
3:01
potential immunotherapy combinations in rcc
-
1:21
dr. choueiri on trials investigating combination regimens for rcc
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
1:43
dr. george on sequencing in renal cell carcinoma